Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llae421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Amithis B Franciozi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mast Cells, Interleukin-17, Folliculitis, Scalp. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Folliculitis decalvans (FD) is a chronic neutrophilic scarring alopecia, the exact pathogenesis of which remains unknown. A recent report on the successful use of a novel anti-interleukin (IL)-17 biologic agent to treat FD and the presence of IL-17-secreting mast cells in other types of scarring alopecias point to a distinct pathogenic mechanism in this disease. Our aim was to study and correlate the expression of IL-17 and mast cells in lesional and nonlesional scalp areas of patients with FD, using immunohistochemical techniques. There was significantly greater expression of IL-17 and mast cells in lesional compared with nonlesional scalp areas (P < 0.05). We also found a significantly positive correlation between IL-17 and tryptase-immunolabelled mast cells in nonlesional scalp (r = 0.64), highlighting the role of IL-17-secreting mast cells in ‘normal-appearing’ sites of FD. These findings suggest that novel treatments targeting both IL-17 and mast cells may be potentially beneficial in controlling the chronic inflammatory status of FD, especially for patients with recalcitrant FD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
- Department of Pathology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
ORCID-Profile: Amithis B Franciozi, Mirian N Sotto, Isabella Doche
Zitieren
APA
Franciozi, A. B., Sotto, M. N., Rivitti-Machado, M. C. M., Pagliari, C., & Doche, I. (2025). Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae421
Vancouver
Franciozi AB, Sotto MN, Rivitti-Machado MCM, Pagliari C, Doche I. Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llae421
BibTeX
@article{Franciozi2025,
author = {Franciozi, Amithis B and Sotto, Mirian N and Rivitti-Machado, Maria C M and Pagliari, Carla and Doche, Isabella},
title = {Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llae421}
}
EUVIMED